Bristol Myers Squibb stock (NYSE: BMY) has gained 7% this year, outperforming the S&P 500 which has declined 1%. BMS’s strong Q4 performance has helped drive its positive momentum. While markets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback